ImmunityBio converts from Immunomedics | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ImmunityBio converts from Immunomedics

An SI Board Since February 2023

Posts	SubjectMarks	Bans	Symbol
1493	51	0	IBRX

Emcee: TinfoilHat	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1360	I see it takes 6 years to complete a drug study on patients with Stage IV lung c	waitwatchwander	1	January 21
1359	looks like it is up to 47% now - here is the link .... it has really jumped the	luckydog88	1	January 21
1358	Oops. Thanks	mannamal	-	January 21
1357	Phase 2, but thanks for the heads up!	erippetoe	1	January 21
1356	New phase one trials clinicaltrials.gov	mannamal	1	January 21
1355	borrow rate up to 40% now...	erippetoe	2	January 21
1354	40% short interest can cause a lot of volume lol. Speaking of bubbles, I've	ghettogoulash	-	January 20
1353	Nope, still ghetto. Might celebrate one day with a nice Ripasso.	ghettogoulash	1	January 20
1352	over 200million volume [over 2/3 of float ] and short volume was 120M dec 2025..	urslor	-	January 20
1351	IBRX just had its strongest rally since Anktiva was approved 2 years ago. The vo	Olecranon	1	January 20
1350	I love Amarone’s!	jargonweary	-	January 20
1349	are you the reason for the monster volume?	urslor	-	January 20
1348	I did the same. Feels like easy money. Let’s hope it stays that way	zagnut1	-	January 20
1347	Sold some $5 and $5.5 puts, which is what I tend to do when I am bullish, premiu	ghettogoulash	-	January 20
1346	This is actually good news-- FDA is apparently open to discussions now. Last I h	ghettogoulash	6	January 20
1345	time for another Amarone tonight...	urslor	2	January 20
1344	probably going to have to raise it again tomorrow.... lol	erippetoe	1	January 20
1343	This morning: Piper Sandler analyst Joseph Catanzaro maintains ImmunityBio(IBR	luckydog88	1	January 20
1342	Looks like this is why the stock lost momentum early this morning - also explain	luckydog88	2	January 20
1341	The price also shows on yahoo finance and seems to be updating a lot so appears	erippetoe	-	January 19
1340	just for informational purposes, and things will change greatly before the morni	luckydog88	2	January 19
1339	This probably only happens with tiered pricing. Retain the J-code for oncology.	ghettogoulash	-	January 19
1338	Furthermore, Anktiva would have no biosimilar competition to lower the price. My	ghettogoulash	-	January 19
1337	Looks like IBRX closed at $7.77 (6.70 euros) in Europe	erippetoe	-	January 19
1336	"Bioshield" sounds like something Elon Musk would come up with, so I n	ghettogoulash	-	January 19

Go to reply# or date (mm/dd/yy):